← SynDRA
L-368899
SynDRA canonical compound SYN1965215 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AVPR1A | AVPR2 | OXT | OXTR |
|---|
| Mechanism of action | oxytocin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- oxytocin receptor antagonist
Cross-references
Synonyms
- L 368899
- UNII-ER33G946JT
- ER33G946JT
- CHEMBL1253853
- L 368,899
- (S)-2-amino-N-((1S,2S,4R)-7,7-dimethyl-1-((4-o-tolylpiperazin-1-ylsulfonyl)methyl)bicyclo[2.2.1]heptan-2-yl)-4-(methylsulfonyl)butanamide
- GTPL2249
- SCHEMBL17423276
- ZINC3923061
- BDBM50326719
- NCGC00485193-01
- 1-(((7,7-Dimethyl-2-(2-amino-4-(methylsulfonyl)butyramido)bicyclo(2.2.1)heptan-1-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine
- Butanamide, 2-amino-N-(7,7-dimethyl-1-(((4-(2-methylphenyl)-1-piperazinyl)sulfonyl)methyl)bicyclo
Look up L-368899 in the interactive SynDRA portal →